The medication-assisted treatment (MAT) market finds applications primarily in the field of addiction treatment. MAT combines behavioral therapy with medications such as methadone, buprenorphine, and naltrexone to manage substance use disorders, especially opioids and alcohol. The dominating segment within the MAT market is opioid addiction treatment. With the opioid crisis gripping many nations, MAT's effectiveness in reducing cravings and withdrawal symptoms has led to its widespread adoption. MAT programs have become a cornerstone in addressing the opioid epidemic, offering hope for recovery and improved quality of life.
According to Data Bridge Market Research, the Global Medication-Assisted (MAT) Treatment Market will grow at a CAGR of 9.4% during the forecast period of 2022 to 2029.
“Reimbursement for medication-assisted treatment (MAT) boost the market’s growth”
The driver behind the use of reimbursement for medication-assisted treatment (MAT) lies in its effectiveness in combating addiction. As governments and healthcare systems recognize the urgency of addressing substance use disorders, they incentivize MAT adoption by offering reimbursement programs. These programs lower the financial burden on patients, making treatment more accessible. Consequently, healthcare providers and facilities are increasingly embracing MAT, thereby bolstering the MAT market's growth as a vital component in the fight against addiction.
What restraints the growth of the global medication-assisted (MAT) treatment market?
“Shortage of skilled professionals restraints the market’s growth”
A significant restraint in the medication-assisted treatment (MAT) market is the shortage of skilled professionals, including physicians, counselors, and nurses, trained in MAT administration. The specialized knowledge and training required for MAT can limit its widespread adoption. The shortage of qualified personnel can hinder the expansion of MAT programs, limiting access to treatment for individuals with substance use disorders.
Segmentation: Global Medication-Assisted Treatment (MAT) Market
The global medication-assisted (MAT) treatment market is segmented on the basis of eight segments: type, products, drug type, dosage form, route of administration, population type, end user, and distribution channel.
- On the basis of type, the global medication-assisted (MAT) treatment market is segmented into medication, and therapy.
- On the basis of products, the global medication-assisted (MAT) treatment market is segmented into buprenorphine and naloxone, naltrexone, buprenorphine, methadone, naloxone, disulfiram, and acamprosate.
- On the basis of drug type, the global medication-assisted (MAT) treatment market is segmented into generics, and branded.
- On the basis of dosage form, the global medication-assisted (MAT) treatment market is segmented into immediate release and extended release.
- On the basis of route of administration, the global medication-assisted (MAT) treatment market is segmented into oral, parenteral, and others.
- On the basis of population type, the global medication-assisted (MAT) treatment market is segmented into adults and teenage.
- On the basis of end user, the global medication-assisted (MAT) treatment market is segmented into rehabilitation clinics, hospitals, speciality centers, homecare, and others.
- On the basis of distribution channel, the global medication-assisted (MAT) treatment market is segmented into hospital pharmacy, direct tender, retail pharmacy, online pharmacy, and others.
Regional Insights: North America is expected to dominate the Global Medication-Assisted Treatment (MAT) Market
North America is poised to maintain market dominance, driven by a growing prevalence of substance use disorders. Ongoing clinical trials and the active participation of pharmaceutical companies contribute to the region's leadership in the medication-assisted treatment (MAT) market. The urgency to address addiction-related challenges, coupled with research and pharmaceutical initiatives, positions North America as a key driver in advancing MAT adoption and its associated treatments
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-medication-assisted-treatment-mat-market
Recent Development
- In April 2021, Adamis Pharmaceuticals Corporation, in collaboration with USWM, introduced a high-dose ZIMHI injectable naloxone product aimed at reducing opioid overdose fatalities. This launch is anticipated to drive growth in the product segment revenue, resulting in an overall market expansion. Additionally, ZIMHI is being offered at a reduced cost to support first responders and community health organizations in their efforts to combat opioid-related emergencies.
The Prominent Key Players Operating in the Global Medication-Assisted Treatment (MAT) Market Include:
- Indivior PLC (U.K.)
- Orexo US Inc. (a subsidiary of Orexo AB) (Sweden)
- Recovery Centers of America (U.S.)
- Alkermes (Ireland)
- Sun Pharmaceutical Industries Ltd. (India)
- Purdue Pharma L.P. (U.S.)
- Taj Pharmaceuticals Limited (India)
- Lannett (U.S.)
- Hikma Pharmaceuticals PLC (Jordan)
- Pfizer Inc. (U.S.)
- Pinnacle Treatment Center (U.S.)
- American Addiction Centers (U.S.)
- Adamis Pharmaceuticals Corporation (U.S.)
- Glenmark Pharmaceutical Inc. (U.S.)
- Viatris Inc. (U.S.)
- Mallinckrodt (U.K.)
- Alvogen (U.S.)
- Accord Healthcare (U.K.)
- VistaPharm, Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Dr. Reddy's Laboratories Ltd. (India)
- Amneal Pharmaceuticals LLC (U.S.)
- Titan Pharmaceuticals, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global medication-assisted (MAT) treatment market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Medication-Assisted Treatment (MAT) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
